Surging demands for early diagnosis of NiV infection is driving the growth of India NIPAH virus diagnostics market, 2017-2027.
According to TechSci report on, “India NIPAH Virus Diagnostics Market By Test Type (RT-PCR v/s ELISA), By Sample (Throat & Nasal Swab, Urine, Blood, Others), By End User (Hospitals & Clinics, Diagnostics Laboratories, Others), By Region, Competition, Forecast & Opportunities, 2027” India NIPAH virus diagnostics market has shown promising growth in historical years until 2020 and is expected to continue its growth in upcoming forecast years, 2023 to 2027. India NIPAH virus diagnostics market owes its growth to factors like increasing demands for effective diagnostic kits.
Surging demand for efficient testing kits for the identification of NIPAH virus infection and its tendency to spread is anticipated to drive the growth of the India NIPAH virus diagnostics market in the upcoming five years.
Expanding healthcare facilities in the country is also actively supporting the growth of the India NIPAH virus diagnostics market in the next five years. Moreover, consistent research and technological advancement in the manufacturing of the advanced diagnostic kits for the identification is further substantiating the growth of the India NIPAH virus diagnostics market in the future five years.
South Indian region is at the most risk for the viral infection and have encountered previous cases of the infection. Surging demand from the consumers from the region are expected to further aid to the growth of the India NIPAH virus diagnostics market in the forecast years, until FY2027. Furthermore, higher mortality rate of the NIPAH virus infection is also influencing the growth of the India NIPAH virus diagnostics market in the forecast period.
Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on “India NIPAH Virus Diagnostics Market”
https://www.techsciresearch.com/report/india-nipah-virus-diagnostics-market/8003.html
The India NIPAH virus diagnostics market is segmented on the basis of test type, sample, end user, competitional landscape, and country analysis. Based on test type, the market is further fragmented into RT PCR and ELISA. ELISA is anticipated to register the largest revenue shares of the market and dominate the market segment in the upcoming five years on the account of its increasing usage to identify the NIPAH virus in the infection spread.
ELISA is Enzyme Linked Immunosorbent Assay; the process analyzes the presence of antibody that is produced by the body’s immune system in the presence of antigens. A monoclonal antibody-based test is specifically designed to detect remaining antigens in the body after the symptoms are detected in the human body.
The antigens instigate production of antibodies specific to themselves, working on the concept of lock-key model, the test is performed on mostly blood samples from the infected patient. RT PCR is anticipated to hold the significant revenue shares of the market in the upcoming five years and dominate the market segment on the account of efficient and effective means of the process of RT PCR.
The method is reverse transcriptase – polymerase chain reaction, which is a lab technique that combines reverse transcription of RNA into DNA. Viruses do not possess their own DNA. They carry RNA as the genetic material and utilizes host cells for the replication. RT PCR process analyzes the process of RNA into DNA transcription and identifies the presence of the type of virus and its infection.
Based on sample, the market is segmented into throat & nasal swab, urine, blood, and others. Blood samples are anticipated to register largest revenue shares of the market and dominate the market segment in the upcoming five years on the account of increased ELISA diagnostic kits that takes in blood samples for the identification of NIPAH virus protein (antibody) and analyze NIPAH virus infection.
Moreover, rapid detection of active NiV infection to support early outbreak detection and case management, and to ensure early implementation of infection control measures, blood are the best samples for the ELISA test, thus driving the growth of the India NIPAH virus diagnostics market in the next five years.
A partial list of market players in the field includes:
- Molbio Diagnostics Pvt. Ltd.
- Krishgen Biosystems
- MyBioSource, Inc.
- Liferiver Bio-Tech (United States) Corp.
Multiple healthcare testing kit manufacturers are expected to join the major market players list, though confirmation from the DCGI for their testing kits are pending and is expected to surge in the market in the near future.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=8003
Customers can also request for 10% free customization on this report.
“Diagnostics laboratories are expected to register largest revenue shares of the market and dominate the market in the upcoming five years on the account of increasing demands for the early diagnosis of the viral infection. Moreover, the dependency of the consumers on the private diagnostics laboratories is further aiding the growth of the India NIPAH virus diagnostics market in the next five years. Infections have surged in past years, and South Indian and East Indian region are most affected. Rapidly increasing cases and their demand for the early diagnosis is surging due to higher mortality rate. New market players are advised to launch innovative testing kits that guarantee earlier and effective diagnosis thus supporting their brand establishments,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“India NIPAH Virus Diagnostics Market By Test Type (RT-PCR v/s ELISA), By Sample (Throat & Nasal Swab, Urine, Blood, Others), By End User (Hospitals & Clinics, Diagnostics Laboratories, Others), By Region, Competition Forecast & Opportunities, FY2027” has evaluated the future growth potential of India NIPAH virus diagnostics market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India NIPAH virus diagnostics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com
